ECMO(体外式膜型人工肺)の世界市場2023年-2027年

◆英語タイトル:Global Extracorporeal Membrane Oxygenation Machines Market 2023-2027

Technavioが発行した調査報告書(IRTNTR40185-23)◆商品コード:IRTNTR40185-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2022年12月23日
◆ページ数:167
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Technavio社の本調査資料によると、世界のECMO(体外式膜型人工肺)市場規模が2022年から2027年まで年平均10.05%成長し、243.6百万ドルに達すると見込まれます。本書では、ECMO(体外式膜型人工肺)の世界市場を調査し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、モダリティ別(静脈瘤、動脈-静脈、静脈動脈)分析、製品別(ECMO装置、ソフトウエア)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア太平洋、その他地域、アメリカ、ドイツ、カナダ、イギリス、中国)分析、推進要因・課題・動向、企業状況、企業分析などの情報を整理しています。また、本レポートには、主要企業としてAbbott Laboratories、Abiomed Inc.、Braile Biomedica、Chalice Medical Ltd.、CytoSorbents Europe GmbH、Eurosets Srl、Fresenius Medical Care AG and Co. KGaA、Getinge AB、LivaNova Plc、MC3 Cardiopulmonary、Medtronic Plc、MicroPort Scientific Corp.、Nipro Corp.、OriGen Biomedical Inc.、Palex Medical SA、Sechrist Industries Inc.、Senko Medical Industry Co. Ltd.、Spectrum Medical Ltd.、Terumo Corp.、Xenios AGなどの企業情報が含まれています。・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界のECMO(体外式膜型人工肺)市場規模:モダリティ別
- 静脈瘤の市場規模
- 動脈-静脈の市場規模
- 静脈動脈の市場規模
・世界のECMO(体外式膜型人工肺)市場規模:製品別
- ECMO装置の市場規模
- ソフトウエアの市場規模
・顧客状況
・世界のECMO(体外式膜型人工肺)市場規模:地域別
- 北米のECMO(体外式膜型人工肺)市場規模
- ヨーロッパのECMO(体外式膜型人工肺)市場規模
- アジア太平洋のECMO(体外式膜型人工肺)市場規模
- その他地域のECMO(体外式膜型人工肺)市場規模
- アメリカのECMO(体外式膜型人工肺)市場規模
- ドイツのECMO(体外式膜型人工肺)市場規模
- カナダのECMO(体外式膜型人工肺)市場規模
- イギリスのECMO(体外式膜型人工肺)市場規模
- 中国のECMO(体外式膜型人工肺)市場規模
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争及びプロモーションなどの主要なパラメーターを分析を活用し、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を整理しています。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査資料は、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

ECMO(体外式膜型人工肺)の世界市場 2023-2027

Technavio社は、ECMO(体外式膜型人工肺)市場をモニターしており、2022年から2027年にかけて243.6百万ドルの成長が予測され、予測期間中のCAGRは10.05%で加速すると予測しています。当レポートでは、ECMO(体外式膜型人工肺)市場について、市場規模や予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析など、包括的な分析を提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、呼吸不全や心不全の罹患率の増加、新製品の上市数の増加、移植手術件数の増加が牽引しています。

TechnavioのECMO(体外式膜型人工肺)市場は以下のように区分されます:

・モダリティ別:
- 静脈
- 動脈-静脈
- 静脈-動脈

・製品別:
- ECMO装置
- ソフトウェア

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間におけるECMO(体外式膜型人工肺)市場の成長を促進する主な理由の1つとして、技術の進歩を挙げています。また、呼吸不全疾患や乳幼児の治療における良好な結果は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、ECMO(体外式膜型人工肺)市場について、以下の分野をカバーしています:
- ECMO(体外式膜型人工肺)市場のサイジング
- ECMO(体外式膜型人工肺)市場予測
- ECMO(体外式膜型人工肺)市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Europe GmbH, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., and Xenios AGなどの企業情報が含まれています。また、ECMO(体外式膜型人工肺)市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Modality
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global extracorporeal membrane oxygenation machines market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global extracorporeal membrane oxygenation machines market 2017 – 2021 ($ million)
o 4.2 Modality Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Modality Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Modality
o 6.1 Market segments
o Exhibit 30: Chart on Modality – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Modality – Market share 2022-2027 (%)
o 6.2 Comparison by Modality
o Exhibit 32: Chart on Comparison by Modality
o Exhibit 33: Data Table on Comparison by Modality
o 6.3 Veno-venous and arterio-venous – Market size and forecast 2022-2027
o Exhibit 34: Chart on Veno-venous and arterio-venous – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Veno-venous and arterio-venous – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Veno-venous and arterio-venous – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Veno-venous and arterio-venous – Year-over-year growth 2022-2027 (%)
o 6.4 Veno-arterial – Market size and forecast 2022-2027
o Exhibit 38: Chart on Veno-arterial – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Veno-arterial – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Veno-arterial – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Veno-arterial – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Modality
o Exhibit 42: Market opportunity by Modality ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 43: Chart on Product – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 45: Chart on Comparison by Product
o Exhibit 46: Data Table on Comparison by Product
o 7.3 ECMO machines – Market size and forecast 2022-2027
o Exhibit 47: Chart on ECMO machines – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on ECMO machines – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on ECMO machines – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on ECMO machines – Year-over-year growth 2022-2027 (%)
o 7.4 Softwares – Market size and forecast 2022-2027
o Exhibit 51: Chart on Softwares – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Softwares – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Softwares – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Softwares – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 55: Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 81: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 Canada – Market size and forecast 2022-2027
o Exhibit 85: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 89: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 97: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 104: Abbott Laboratories – Overview
o Exhibit 105: Abbott Laboratories – Business segments
o Exhibit 106: Abbott Laboratories – Key news
o Exhibit 107: Abbott Laboratories – Key offerings
o Exhibit 108: Abbott Laboratories – Segment focus
o 12.4 Braile Biomedica
o Exhibit 109: Braile Biomedica – Overview
o Exhibit 110: Braile Biomedica – Product / Service
o Exhibit 111: Braile Biomedica – Key offerings
o 12.5 Chalice Medical Ltd.
o Exhibit 112: Chalice Medical Ltd. – Overview
o Exhibit 113: Chalice Medical Ltd. – Product / Service
o Exhibit 114: Chalice Medical Ltd. – Key offerings
o 12.6 Eurosets Srl
o Exhibit 115: Eurosets Srl – Overview
o Exhibit 116: Eurosets Srl – Product / Service
o Exhibit 117: Eurosets Srl – Key offerings
o 12.7 Fresenius Medical Care AG and Co. KGaA
o Exhibit 118: Fresenius Medical Care AG and Co. KGaA – Overview
o Exhibit 119: Fresenius Medical Care AG and Co. KGaA – Business segments
o Exhibit 120: Fresenius Medical Care AG and Co. KGaA – Key news
o Exhibit 121: Fresenius Medical Care AG and Co. KGaA – Key offerings
o Exhibit 122: Fresenius Medical Care AG and Co. KGaA – Segment focus
o 12.8 Getinge AB
o Exhibit 123: Getinge AB – Overview
o Exhibit 124: Getinge AB – Business segments
o Exhibit 125: Getinge AB – Key news
o Exhibit 126: Getinge AB – Key offerings
o Exhibit 127: Getinge AB – Segment focus
o 12.9 LivaNova Plc
o Exhibit 128: LivaNova Plc – Overview
o Exhibit 129: LivaNova Plc – Business segments
o Exhibit 130: LivaNova Plc – Key offerings
o Exhibit 131: LivaNova Plc – Segment focus
o 12.10 MC3 Cardiopulmonary
o Exhibit 132: MC3 Cardiopulmonary – Overview
o Exhibit 133: MC3 Cardiopulmonary – Product / Service
o Exhibit 134: MC3 Cardiopulmonary – Key offerings
o 12.11 Medtronic Plc
o Exhibit 135: Medtronic Plc – Overview
o Exhibit 136: Medtronic Plc – Business segments
o Exhibit 137: Medtronic Plc – Key news
o Exhibit 138: Medtronic Plc – Key offerings
o Exhibit 139: Medtronic Plc – Segment focus
o 12.12 MicroPort Scientific Corp.
o Exhibit 140: MicroPort Scientific Corp. – Overview
o Exhibit 141: MicroPort Scientific Corp. – Business segments
o Exhibit 142: MicroPort Scientific Corp. – Key offerings
o Exhibit 143: MicroPort Scientific Corp. – Segment focus
o 12.13 Nipro Corp.
o Exhibit 144: Nipro Corp. – Overview
o Exhibit 145: Nipro Corp. – Business segments
o Exhibit 146: Nipro Corp. – Key offerings
o Exhibit 147: Nipro Corp. – Segment focus
o 12.14 OriGen Biomedical Inc.
o Exhibit 148: OriGen Biomedical Inc. – Overview
o Exhibit 149: OriGen Biomedical Inc. – Product / Service
o Exhibit 150: OriGen Biomedical Inc. – Key offerings
o 12.15 Sechrist Industries Inc.
o Exhibit 151: Sechrist Industries Inc. – Overview
o Exhibit 152: Sechrist Industries Inc. – Product / Service
o Exhibit 153: Sechrist Industries Inc. – Key offerings
o 12.16 Terumo Corp.
o Exhibit 154: Terumo Corp. – Overview
o Exhibit 155: Terumo Corp. – Business segments
o Exhibit 156: Terumo Corp. – Key news
o Exhibit 157: Terumo Corp. – Key offerings
o Exhibit 158: Terumo Corp. – Segment focus
o 12.17 Xenios AG
o Exhibit 159: Xenios AG – Overview
o Exhibit 160: Xenios AG – Product / Service
o Exhibit 161: Xenios AG – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 162: Inclusions checklist
o Exhibit 163: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 164: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 165: Research methodology
o Exhibit 166: Validation techniques employed for market sizing
o Exhibit 167: Information sources
o 13.5 List of abbreviations
o Exhibit 168: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Modality
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global extracorporeal membrane oxygenation machines market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Modality Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Modality – Market share 2022-2027 (%)
Exhibits31: Data Table on Modality – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Modality
Exhibits33: Data Table on Comparison by Modality
Exhibits34: Chart on Veno-venous and arterio-venous – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Veno-venous and arterio-venous – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Veno-venous and arterio-venous – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Veno-venous and arterio-venous – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Veno-arterial – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Veno-arterial – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Veno-arterial – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Veno-arterial – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Modality ($ million)
Exhibits43: Chart on Product – Market share 2022-2027 (%)
Exhibits44: Data Table on Product – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Product
Exhibits46: Data Table on Comparison by Product
Exhibits47: Chart on ECMO machines – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on ECMO machines – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on ECMO machines – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on ECMO machines – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Softwares – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Softwares – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Softwares – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Softwares – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Product ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: Abbott Laboratories – Overview
Exhibits105: Abbott Laboratories – Business segments
Exhibits106: Abbott Laboratories – Key news
Exhibits107: Abbott Laboratories – Key offerings
Exhibits108: Abbott Laboratories – Segment focus
Exhibits109: Braile Biomedica – Overview
Exhibits110: Braile Biomedica – Product / Service
Exhibits111: Braile Biomedica – Key offerings
Exhibits112: Chalice Medical Ltd. – Overview
Exhibits113: Chalice Medical Ltd. – Product / Service
Exhibits114: Chalice Medical Ltd. – Key offerings
Exhibits115: Eurosets Srl – Overview
Exhibits116: Eurosets Srl – Product / Service
Exhibits117: Eurosets Srl – Key offerings
Exhibits118: Fresenius Medical Care AG and Co. KGaA – Overview
Exhibits119: Fresenius Medical Care AG and Co. KGaA – Business segments
Exhibits120: Fresenius Medical Care AG and Co. KGaA – Key news
Exhibits121: Fresenius Medical Care AG and Co. KGaA – Key offerings
Exhibits122: Fresenius Medical Care AG and Co. KGaA – Segment focus
Exhibits123: Getinge AB – Overview
Exhibits124: Getinge AB – Business segments
Exhibits125: Getinge AB – Key news
Exhibits126: Getinge AB – Key offerings
Exhibits127: Getinge AB – Segment focus
Exhibits128: LivaNova Plc – Overview
Exhibits129: LivaNova Plc – Business segments
Exhibits130: LivaNova Plc – Key offerings
Exhibits131: LivaNova Plc – Segment focus
Exhibits132: MC3 Cardiopulmonary – Overview
Exhibits133: MC3 Cardiopulmonary – Product / Service
Exhibits134: MC3 Cardiopulmonary – Key offerings
Exhibits135: Medtronic Plc – Overview
Exhibits136: Medtronic Plc – Business segments
Exhibits137: Medtronic Plc – Key news
Exhibits138: Medtronic Plc – Key offerings
Exhibits139: Medtronic Plc – Segment focus
Exhibits140: MicroPort Scientific Corp. – Overview
Exhibits141: MicroPort Scientific Corp. – Business segments
Exhibits142: MicroPort Scientific Corp. – Key offerings
Exhibits143: MicroPort Scientific Corp. – Segment focus
Exhibits144: Nipro Corp. – Overview
Exhibits145: Nipro Corp. – Business segments
Exhibits146: Nipro Corp. – Key offerings
Exhibits147: Nipro Corp. – Segment focus
Exhibits148: OriGen Biomedical Inc. – Overview
Exhibits149: OriGen Biomedical Inc. – Product / Service
Exhibits150: OriGen Biomedical Inc. – Key offerings
Exhibits151: Sechrist Industries Inc. – Overview
Exhibits152: Sechrist Industries Inc. – Product / Service
Exhibits153: Sechrist Industries Inc. – Key offerings
Exhibits154: Terumo Corp. – Overview
Exhibits155: Terumo Corp. – Business segments
Exhibits156: Terumo Corp. – Key news
Exhibits157: Terumo Corp. – Key offerings
Exhibits158: Terumo Corp. – Segment focus
Exhibits159: Xenios AG – Overview
Exhibits160: Xenios AG – Product / Service
Exhibits161: Xenios AG – Key offerings
Exhibits162: Inclusions checklist
Exhibits163: Exclusions checklist
Exhibits164: Currency conversion rates for US$
Exhibits165: Research methodology
Exhibits166: Validation techniques employed for market sizing
Exhibits167: Information sources
Exhibits168: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ECMO(体外式膜型人工肺)の世界市場2023年-2027年(Global Extracorporeal Membrane Oxygenation Machines Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆